New Wave Group AB ser. B (0KIZ)
London Stock Exchange · UK · prices in SEK · close of 27 Oct 2026
Key indicators
| Last close | SEK 100.80 |
|---|---|
| 52-week range | 84.75 – 124.70 |
| Return, 1 month / 3 months | +12.8% / +7.9% |
| Return, 1 year / 3 years | −12.6% / +55.0% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 24.4% |
| Worst drawdown (1 year) | -27.3% |
| Average daily value traded | 1.02M SEK |
| Dividend yield | 3.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
New Wave Group is a Swedish company based in Gothenburg that designs, acquires and develops brands for corporate promotional products, sportswear and gifts. Its brands include Craft, Clique, Cutter and Buck, and Kayoba, which supply clothing, bags, accessories and leisure items. Customers include companies buying promotional goods, sports clubs, retailers and consumers, and the group operates through its own sales companies and distributors in markets across Europe and North America.
New Wave Group AB ser. B trades under the code 0KIZ on the London Stock Exchange in UK, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
New Wave Group AB ser. B (0KIZ) trades on the London Stock Exchange in UK. It last closed at SEK 100.80 on 27 October 2026.
Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 1,601 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.6% and over the last three months it rose 7.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.3% | ||
| From 52-week high | -15.3% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 7.9% | ||
| 6-month return | 5.9% | ||
| 12-month return, skipping the last month | -22.5% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.3% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.02M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 70 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 3.2% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.4% |
|---|---|
| 1 month | +12.8% |
| 3 months | +7.9% |
| 6 months | +5.9% |
| 1 year | −12.6% |
| 3 years | +55.0% |
| 5 years | +64.0% |
Signals
| 50-day / 200-day average | 91.75 / 95.71 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.50 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | SEK 1.5000 |
| 1 Dec 2025 | SEK 1.7500 |
| 7 May 2025 | SEK 1.7500 |
| 29 Nov 2024 | SEK 1.7500 |
| 17 May 2024 | SEK 1.7500 |
| 20 Nov 2023 | SEK 1.6200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.